Candriam SCA’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-214,063
| Closed | -$3.71M | – | 697 |
|
|
2025
Q1 | $3.71M | Sell |
214,063
-1,358
| -0.6% | -$23.5K | 0.02% | 391 |
|
|
2024
Q4 | $5.84M | Buy |
215,421
+80,421
| +60% | +$2.18M | 0.03% | 332 |
|
|
2024
Q3 | $5.92M | Hold |
135,000
| – | – | 0.03% | 335 |
|
|
2024
Q2 | $5.3M | Hold |
135,000
| – | – | 0.03% | 334 |
|
|
2024
Q1 | $5.79M | Sell |
135,000
-75,000
| -36% | -$3.21M | 0.04% | 322 |
|
|
2023
Q4 | $8.56M | Buy |
+210,000
| New | +$8.56M | 0.06% | 272 |
|